US 9540440
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
granted A61KA61K39/39533A61K47/6817
Quick answer
US patent 9540440 (Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K39/39533, A61K47/6817, A61K47/6849